- Home
- XMTR vs HCM Comparison
XMTR vs HCM Comparison
Compare XMTR & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XMTR
- HCM
- Stock Information
- Founded
- XMTR 2013
- HCM 2000
- Country
- XMTR United States
- HCM Hong Kong
- Employees
- XMTR N/A
- HCM 1811
- Industry
- XMTR Industrial Machinery/Components
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- XMTR Technology
- HCM Health Care
- Exchange
- XMTR Nasdaq
- HCM Nasdaq
- Market Cap
- XMTR 2.4B
- HCM 2.6B
- IPO Year
- XMTR 2021
- HCM N/A
- Fundamental
- Price
- XMTR $49.68
- HCM $15.97
- Analyst Decision
- XMTR Buy
- HCM
- Analyst Count
- XMTR 11
- HCM 0
- Target Price
- XMTR $37.00
- HCM N/A
- AVG Volume (30 Days)
- XMTR 750.5K
- HCM 58.8K
- Earning Date
- XMTR 11-04-2025
- HCM 08-07-2025
- Dividend Yield
- XMTR N/A
- HCM N/A
- EPS Growth
- XMTR N/A
- HCM N/A
- EPS
- XMTR N/A
- HCM 0.53
- Revenue
- XMTR $603,762,000.00
- HCM $602,197,000.00
- Revenue This Year
- XMTR $22.43
- HCM $2.73
- Revenue Next Year
- XMTR $17.51
- HCM $17.33
- P/E Ratio
- XMTR N/A
- HCM $5.82
- Revenue Growth
- XMTR 20.19
- HCM N/A
- 52 Week Low
- XMTR $16.11
- HCM $11.51
- 52 Week High
- XMTR $51.68
- HCM $21.50
- Technical
- Relative Strength Index (RSI)
- XMTR 61.19
- HCM 50.71
- Support Level
- XMTR $45.62
- HCM $14.69
- Resistance Level
- XMTR $51.68
- HCM $15.50
- Average True Range (ATR)
- XMTR 2.60
- HCM 0.29
- MACD
- XMTR -0.26
- HCM -0.02
- Stochastic Oscillator
- XMTR 75.53
- HCM 68.09
About XMTR Xometry Inc.
Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of its revenue is derived from the U.S. segment.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.